Table 1.
Baseline characteristics.
| Variables | Number or Median (IQR) |
|---|---|
| Age (years) | 73 (66, 79) |
| Gender, male/female | 272/149 |
| BMI (kg/m2) | 21.0 (18.8, 23.6) |
| Hb (g/dL) | 11.9 (10.4, 13.3) |
| Serum albumin (g/dL) | 3.5 (3.0, 3.9) |
| CRP (mg/dL) | 0.75 (0.19, 4.39) |
| GPS, 0/1/2 | 177/91/153 |
| Total lymphocyte count (/μL) | 1081 (767, 1490) |
| ALT (IU/l) | 22 (13, 52.5) |
| Platelet count × 104/mm3 | 21.4 (15.7, 28.0) |
| eGFR (mL/min/1.73m2) | 68 (55, 82) |
| ECOG-PS, 0/1/2/3/4 | 201/78/38/61/43 |
| SARC-F score, 0/1/2/3/4 or more | 198/53/38/29/103 |
| Breakdown of advanced cancers (number (%)) | |
| Esophageal cancer | 69 (16.4%) |
| Gastric cancer | 63 (15.0%) |
| Biliary tract cancer | 62 (14.7%) |
| Pancreatic cancer | 78 (18.5%) |
| Hepatocellular carcinoma | 55 (13.1%) |
| Colorectal cancer | 93 (22.1%) |
| Small intestine cancer | 1 (0.2%) |
BMI; body mass index, CRP; C reactive protein, GPS; Glasgow prognostic score, ALT; alanine aminotransferase, eGFR; estimated glomerular filtration rate, IQR; interquartile range.